ArticleBriefings in bioinformatics2025
CluVar: clustering of variants using autoencoder for inferring cancer subclones from single cell RNA sequencing data.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy.Cancer drug resistance (Alhambra, Calif.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tumor tissues are composed of malignant subclones with diverse genetic profiles. Reconstructing the evolutionary trajectory of these subclones is crucial for understanding how tumors acquire malignant traits. However, current approaches to subclonal tree reconstruction are limited either by their reliance on single-cell DNA sequencing (scDNA-seq) that involve a small number of cells and thus yield low-resolution results, or using single-cell RNA sequencing (scRNA-seq) data, which despite including larger cell populations, remain susceptible to bias from high dropout rates and technical noise. Here, we introduce CluVar, an autoencoder-based framework for inferring the phylogeny of cancer subclones from scRNA-seq data using mutation profile analysis. To address the extensive missing variant information inherent in scRNA-seq datasets, CluVar incorporates a customized loss function and multiple hidden layers optimized for clustering. CluVar demonstrated superior performance in reconstructing phylogenetic trees of cancer subclones under a range of erroneous conditions. When applied to cancer scRNA-seq data, the phylogenetic tree predicted using CluVar aligned well with the transcriptomic profiles. These findings highlight its utility for tracing evolutionary trajectories and identifying novel variants associated with cancer progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.